{
  "DOI": "10.1007/s10689-018-00117-1",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-018-00117-1",
  "alternative-id": [
    "117"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 1,
      "value": "9 January 2019"
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Biller",
      "given": "Leah H.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Syngal",
      "given": "Sapna",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yurgelun",
      "given": "Matthew B.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        1,
        9
      ]
    ],
    "date-time": "2019-01-09T09:21:28Z",
    "timestamp": 1547025688000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        1,
        9
      ]
    ],
    "date-time": "2020-01-09T00:10:40Z",
    "timestamp": 1578528640000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        5,
        1
      ]
    ],
    "date-time": "2024-05-01T00:47:05Z",
    "timestamp": 1714524425393
  },
  "is-referenced-by-count": 68,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2019,
        1,
        9
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2019,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            1,
            9
          ]
        ],
        "date-time": "2019-01-09T00:00:00Z",
        "timestamp": 1546992000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-018-00117-1/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-018-00117-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-018-00117-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "211-219",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2019,
        1,
        9
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        1,
        9
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/nrc3878",
      "author": "HT Lynch",
      "doi-asserted-by": "publisher",
      "journal-title": "Nat Rev Cancer",
      "key": "117_CR1",
      "unstructured": "Lynch HT, Snyder CL, Shaw TG, Heinen CD, Hitchins MP (2015) Milestones of Lynch syndrome: 1895–2015. Nat Rev Cancer. \n                    https://doi.org/10.1038/nrc3878",
      "year": "2015"
    },
    {
      "DOI": "10.1126/science.8484122",
      "author": "SN Thibodeau",
      "doi-asserted-by": "publisher",
      "first-page": "816",
      "issue": "5109",
      "journal-title": "Science",
      "key": "117_CR2",
      "unstructured": "Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260(5109):816–819",
      "volume": "260",
      "year": "1993"
    },
    {
      "DOI": "10.1126/science.8484121",
      "author": "LA Aaltonen",
      "doi-asserted-by": "publisher",
      "first-page": "812",
      "issue": "5109",
      "journal-title": "Science",
      "key": "117_CR3",
      "unstructured": "Aaltonen LA, Peltomaki P, Leach FS et al (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260(5109):812–816",
      "volume": "260",
      "year": "1993"
    },
    {
      "DOI": "10.1038/363558a0",
      "author": "Y Ionov",
      "doi-asserted-by": "publisher",
      "first-page": "558",
      "issue": "6429",
      "journal-title": "Nature",
      "key": "117_CR4",
      "unstructured": "Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363(6429):558–561. \n                    https://doi.org/10.1038/363558a0",
      "volume": "363",
      "year": "1993"
    },
    {
      "DOI": "10.1056/NEJMoa043146",
      "author": "H Hampel",
      "doi-asserted-by": "publisher",
      "first-page": "1851",
      "issue": "18",
      "journal-title": "N Engl J Med",
      "key": "117_CR5",
      "unstructured": "Hampel H, Frankel WL, Martin E et al (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352(18):1851–1860. \n                    https://doi.org/10.1056/NEJMoa043146",
      "volume": "352",
      "year": "2005"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-06-1114",
      "author": "H Hampel",
      "doi-asserted-by": "publisher",
      "first-page": "7810",
      "issue": "15",
      "journal-title": "Cancer Res",
      "key": "117_CR6",
      "unstructured": "Hampel H, Frankel W, Panescu J et al (2006) Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66(15):7810–7817. \n                    https://doi.org/10.1158/0008-5472.CAN-06-1114",
      "volume": "66",
      "year": "2006"
    },
    {
      "key": "117_CR7",
      "unstructured": "NCCN clinical practice guidelines in oncology: genetic/familial high risk assessment: colorectal. Version 1.2018. \n                    https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf\n                    \n                  . Published July 12, 2018. Accessed 1 Aug 2018"
    },
    {
      "DOI": "10.1038/ajg.2014.435",
      "author": "S Syngal",
      "doi-asserted-by": "publisher",
      "journal-title": "Am J Gastroenterol",
      "key": "117_CR8",
      "unstructured": "Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW (2015) ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. \n                    https://doi.org/10.1038/ajg.2014.435",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ajg.2014.186",
      "author": "FM Giardiello",
      "doi-asserted-by": "publisher",
      "first-page": "1159",
      "issue": "8",
      "journal-title": "Am J Gastroenterol",
      "key": "117_CR9",
      "unstructured": "Giardiello FM, Allen JI, Axilbund JE et al (2014) Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol 109(8):1159–1179. \n                    https://doi.org/10.1038/ajg.2014.186",
      "volume": "109",
      "year": "2014"
    },
    {
      "DOI": "10.1093/annonc/mdt209",
      "author": "J Balmana",
      "doi-asserted-by": "publisher",
      "first-page": "vi73",
      "issue": "Suppl 6",
      "journal-title": "Ann Oncol Off J Eur Soc Med Oncol",
      "key": "117_CR10",
      "unstructured": "Balmana J, Balaguer F, Cervantes A, Arnold D (2013) Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines. Ann Oncol Off J Eur Soc Med Oncol 24(Suppl 6):vi73–80. \n                    https://doi.org/10.1093/annonc/mdt209",
      "volume": "24",
      "year": "2013"
    },
    {
      "DOI": "10.1136/gutjnl-2012-304356",
      "author": "HFA Vasen",
      "doi-asserted-by": "publisher",
      "first-page": "812",
      "issue": "6",
      "journal-title": "Gut",
      "key": "117_CR11",
      "unstructured": "Vasen HFA, Blanco I, Aktan-Collan K et al (2013) Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 62(6):812–823. \n                    https://doi.org/10.1136/gutjnl-2012-304356",
      "volume": "62",
      "year": "2013"
    },
    {
      "DOI": "10.1200/JCO.2014.58.1322",
      "author": "EM Stoffel",
      "doi-asserted-by": "publisher",
      "first-page": "209",
      "issue": "2",
      "journal-title": "J Clin Oncol",
      "key": "117_CR12",
      "unstructured": "Stoffel EM, Mangu PB, Gruber SB et al (2015) Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol 33(2):209–217. \n                    https://doi.org/10.1200/JCO.2014.58.1322",
      "volume": "33",
      "year": "2015"
    },
    {
      "key": "117_CR13",
      "unstructured": "NCCN clinical practice guidelines in oncology: uterine neoplasm. Version 1.2019.\n                    https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf\n                    \n                  . Published October 17, 2018. Accessed 25 Oct 2018"
    },
    {
      "key": "117_CR14",
      "unstructured": "SGO Clinical Practice Statement: Screening for Lynch Syndrome in Endometrial Cancer. \n                    https://www.sgo.org/clinical-practice/guidelines/screening-for-lynch-syndrome-in-endometrial-cancer/\n                    \n                  . Published March 2014. Accessed Oct 2018"
    },
    {
      "DOI": "10.1016/S0016-5085(00)70168-5",
      "author": "HJ Jarvinen",
      "doi-asserted-by": "publisher",
      "first-page": "829",
      "issue": "5",
      "journal-title": "Gastroenterology",
      "key": "117_CR15",
      "unstructured": "Jarvinen HJ, Aarnio M, Mustonen H et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118(5):829–834",
      "volume": "118",
      "year": "2000"
    },
    {
      "DOI": "10.1056/NEJMoa052627",
      "author": "KM Schmeler",
      "doi-asserted-by": "publisher",
      "first-page": "261",
      "issue": "3",
      "journal-title": "N Engl J Med",
      "key": "117_CR16",
      "unstructured": "Schmeler KM, Lynch HT, Chen L et al (2006) Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354(3):261–269. \n                    https://doi.org/10.1056/NEJMoa052627",
      "volume": "354",
      "year": "2006"
    },
    {
      "DOI": "10.1016/S0140-6736(11)61049-0",
      "author": "J Burn",
      "doi-asserted-by": "publisher",
      "first-page": "2081",
      "issue": "9809",
      "journal-title": "Lancet",
      "key": "117_CR17",
      "unstructured": "Burn J, Gerdes AM, MacRae F et al (2011) Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 378(9809):2081–2087. \n                    https://doi.org/10.1016/S0140-6736(11)61049-0",
      "volume": "378",
      "year": "2011"
    },
    {
      "DOI": "10.1056/NEJMoa022289",
      "author": "CM Ribic",
      "doi-asserted-by": "publisher",
      "first-page": "247",
      "issue": "3",
      "journal-title": "N Engl J Med",
      "key": "117_CR18",
      "unstructured": "Ribic CM, Sargent DJ, Moore MJ et al (2003) Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349(3):247–257. \n                    https://doi.org/10.1056/NEJMoa022289",
      "volume": "349",
      "year": "2003"
    },
    {
      "DOI": "10.1200/JCO.2009.27.1825",
      "author": "DJ Sargent",
      "doi-asserted-by": "publisher",
      "first-page": "3219",
      "issue": "20",
      "journal-title": "J Clin Oncol",
      "key": "117_CR19",
      "unstructured": "Sargent DJ, Marsoni S, Monges G et al (2010) Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol 28(20):3219–3226. \n                    https://doi.org/10.1200/JCO.2009.27.1825",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2008.17.5950",
      "author": "H Hampel",
      "doi-asserted-by": "publisher",
      "journal-title": "J Clin Oncol",
      "key": "117_CR20",
      "unstructured": "Hampel H, Frankel WL, Martin E et al (2008) Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol. \n                    https://doi.org/10.1200/JCO.2008.17.5950",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2016.71.0012",
      "author": "MB Yurgelun",
      "doi-asserted-by": "publisher",
      "first-page": "1086",
      "issue": "10",
      "journal-title": "J Clin Oncol",
      "key": "117_CR21",
      "unstructured": "Yurgelun MB, Kulke MH, Fuchs CS et al (2017) Cancer susceptibility gene mutations in individuals with colorectal cancer. J Clin Oncol 35(10):1086–1095. \n                    https://doi.org/10.1200/JCO.2016.71.0012",
      "volume": "35",
      "year": "2017"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-16-0693",
      "author": "AK Win",
      "doi-asserted-by": "publisher",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "117_CR22",
      "unstructured": "Win AK, Jenkins MA, Dowty JG et al (2017) Prevalence and penetrance of major genes and polygenes for colorectal cancer. Cancer Epidemiol Biomarkers Prev. \n                    https://doi.org/10.1158/1055-9965.EPI-16-0693",
      "year": "2017"
    },
    {
      "DOI": "10.1111/cge.12529",
      "author": "G Ponti",
      "doi-asserted-by": "publisher",
      "first-page": "507",
      "issue": "6",
      "journal-title": "Clin Genet",
      "key": "117_CR23",
      "unstructured": "Ponti G, Castellsague E, Ruini C, Percesepe A, Tomasi A (2015) Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome. Clin Genet 87(6):507–516. \n                    https://doi.org/10.1111/cge.12529",
      "volume": "87",
      "year": "2015"
    },
    {
      "DOI": "10.1200/JCO.2016.34.15_suppl.1542",
      "doi-asserted-by": "crossref",
      "key": "117_CR24",
      "unstructured": "Haraldsdottir S, Rafnar T, Frankel WL et al. Comprehensive population-wide detection of Lynch syndrome in Iceland. ASCO Meet Abstr. 2016"
    },
    {
      "DOI": "10.1186/1897-4287-11-18",
      "author": "M Dominguez-Valentin",
      "doi-asserted-by": "publisher",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "117_CR25",
      "unstructured": "Dominguez-Valentin M, Nilbert M, Wernhoff P et al (2013) Mutation spectrum in South American Lynch syndrome families. Hered Cancer Clin Pract. \n                    https://doi.org/10.1186/1897-4287-11-18",
      "year": "2013"
    },
    {
      "DOI": "10.1053/j.gastro.2015.07.052",
      "author": "RSC Guindalini",
      "doi-asserted-by": "publisher",
      "journal-title": "Gastroenterology",
      "key": "117_CR26",
      "unstructured": "Guindalini RSC, Win AK, Gulden C et al (2015) Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. Gastroenterology. \n                    https://doi.org/10.1053/j.gastro.2015.07.052",
      "year": "2015"
    },
    {
      "DOI": "10.1111/cge.13026",
      "author": "D Dymerska",
      "doi-asserted-by": "publisher",
      "journal-title": "Clin Genet",
      "key": "117_CR27",
      "unstructured": "Dymerska D, Gołębiewska K, Kuświk M et al (2017) New EPCAM founder deletion in Polish population. Clin Genet. \n                    https://doi.org/10.1111/cge.13026",
      "year": "2017"
    },
    {
      "DOI": "10.1038/ncomms14755",
      "author": "S Haraldsdottir",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Nat Commun",
      "key": "117_CR28",
      "unstructured": "Haraldsdottir S, Rafnar T, Frankel WL et al (2017) Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2. Nat Commun 8:1–11. \n                    https://doi.org/10.1038/ncomms14755",
      "volume": "8",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nature11252",
      "author": "Cancer Genom Atlas",
      "doi-asserted-by": "publisher",
      "journal-title": "Nature",
      "key": "117_CR29",
      "unstructured": "Cancer Genom Atlas (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature. \n                    https://doi.org/10.1038/nature11252",
      "year": "2012"
    },
    {
      "DOI": "10.1158/1940-6207.CAPR-11-0519",
      "author": "MB Yurgelun",
      "doi-asserted-by": "publisher",
      "first-page": "574 LP",
      "issue": "4",
      "journal-title": "Cancer Prev Res",
      "key": "117_CR30",
      "unstructured": "Yurgelun MB, Goel A, Hornick JL et al (2012) Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res 5(4):574 LP–L582",
      "volume": "5",
      "year": "2012"
    },
    {
      "DOI": "10.1002/ijc.31300",
      "author": "A Ahadova",
      "doi-asserted-by": "publisher",
      "first-page": "139",
      "issue": "1",
      "journal-title": "Int J Cancer",
      "key": "117_CR31",
      "unstructured": "Ahadova A, Gallon R, Gebert J et al (2018) Three molecular pathways model colorectal carcinogenesis in Lynch syndrome. Int J Cancer 143(1):139–150. \n                    https://doi.org/10.1002/ijc.31300",
      "volume": "143",
      "year": "2018"
    },
    {
      "DOI": "10.1016/S1470-2045(12)70109-2",
      "author": "M Kloor",
      "doi-asserted-by": "publisher",
      "first-page": "598",
      "issue": "6",
      "journal-title": "Lancet Oncol",
      "key": "117_CR32",
      "unstructured": "Kloor M, Huth C, Voigt AY et al (2012) Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study. Lancet Oncol 13(6):598–606. \n                    https://doi.org/10.1016/S1470-2045(12)70109-2",
      "volume": "13",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10689-016-9899-z",
      "author": "A Ahadova",
      "doi-asserted-by": "publisher",
      "first-page": "579",
      "issue": "4",
      "journal-title": "Fam Cancer",
      "key": "117_CR33",
      "unstructured": "Ahadova A, von Knebel Doeberitz M, Bläker H, Kloor M (2016) CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome. Fam Cancer 15(4):579–586. \n                    https://doi.org/10.1007/s10689-016-9899-z",
      "volume": "15",
      "year": "2016"
    },
    {
      "DOI": "10.1136/gutjnl-2016-311403",
      "author": "P Moller",
      "doi-asserted-by": "publisher",
      "first-page": "1657",
      "issue": "9",
      "journal-title": "Gut",
      "key": "117_CR34",
      "unstructured": "Moller P, Seppala T, Bernstein I et al (2017) Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database. Gut 66(9):1657–1664. \n                    https://doi.org/10.1136/gutjnl-2016-311403",
      "volume": "66",
      "year": "2017"
    },
    {
      "DOI": "10.1053/j.gastro.2013.01.044",
      "author": "M Rodriguez-Soler",
      "doi-asserted-by": "publisher",
      "first-page": "924",
      "issue": "5",
      "journal-title": "Gastroenterology",
      "key": "117_CR35",
      "unstructured": "Rodriguez-Soler M, Perez-Carbonell L, Guarinos C et al (2013) Risk of cancer in cases of suspected Lynch syndrome without germline mutation. Gastroenterology 144(5):924–926. \n                    https://doi.org/10.1053/j.gastro.2013.01.044",
      "volume": "144",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.humpath.2018.04.017",
      "author": "JA Hemminger",
      "doi-asserted-by": "publisher",
      "journal-title": "Hum Pathol",
      "key": "117_CR36",
      "unstructured": "Hemminger JA, Pearlman R, Haraldsdottir S et al (2018) Histology of colorectal adenocarcinoma with double somatic mismatch-repair mutations is indistinguishable from those caused by Lynch syndrome. Hum Pathol. \n                    https://doi.org/10.1016/j.humpath.2018.04.017",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s10689-012-9568-9",
      "author": "I Sourrouille",
      "doi-asserted-by": "publisher",
      "journal-title": "Fam Cancer",
      "key": "117_CR37",
      "unstructured": "Sourrouille I, Coulet F, Lefevre JH et al (2013) Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors. Fam Cancer. \n                    https://doi.org/10.1007/s10689-012-9568-9",
      "year": "2013"
    },
    {
      "DOI": "10.1053/j.gastro.2014.08.041",
      "author": "S Haraldsdottir",
      "doi-asserted-by": "publisher",
      "first-page": "1308",
      "issue": "6",
      "journal-title": "Gastroenterology",
      "key": "117_CR38",
      "unstructured": "Haraldsdottir S, Hampel H, Tomsic J et al (2014) Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. Gastroenterology 147(6):1308–1316.e1. \n                    https://doi.org/10.1053/j.gastro.2014.08.041",
      "volume": "147",
      "year": "2014"
    },
    {
      "DOI": "10.1001/jamaoncol.2018.0104",
      "author": "H Hampel",
      "doi-asserted-by": "publisher",
      "first-page": "806",
      "issue": "6",
      "journal-title": "JAMA Oncol",
      "key": "117_CR39",
      "unstructured": "Hampel H, Pearlman R, Beightol M et al (2018) Assessment of tumor sequencing as a replacement for Lynch syndrome screening and current molecular tests for patients with colorectal cancer. JAMA Oncol 4(6):806–813. \n                    https://doi.org/10.1001/jamaoncol.2018.0104",
      "volume": "4",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.cgh.2017.06.038",
      "author": "DG Luba",
      "doi-asserted-by": "publisher",
      "first-page": "49",
      "issue": "1",
      "journal-title": "Clin Gastroenterol Hepatol",
      "key": "117_CR40",
      "unstructured": "Luba DG, DiSario JA, Rock C et al (2018) Community practice implementation of a self-administered version of PREMM1,2,6 to assess risk for Lynch syndrome. Clin Gastroenterol Hepatol 16(1):49–58. \n                    https://doi.org/10.1016/j.cgh.2017.06.038",
      "volume": "16",
      "year": "2018"
    },
    {
      "DOI": "10.1200/JCO.2016.69.6120",
      "author": "F Kastrinos",
      "doi-asserted-by": "publisher",
      "journal-title": "J Clin Oncol",
      "key": "117_CR41",
      "unstructured": "Kastrinos F, Uno H, Ukaegbu C et al (2017) Development \u0026 validation of the PREMM5 model for comprehensive risk assessment of lynch syndrome. J Clin Oncol. \n                    https://doi.org/10.1200/JCO.2016.69.6120",
      "year": "2017"
    },
    {
      "DOI": "10.1053/j.gastro.2015.05.006",
      "author": "MB Yurgelun",
      "doi-asserted-by": "publisher",
      "first-page": "604",
      "issue": "3",
      "journal-title": "Gastroenterology",
      "key": "117_CR42",
      "unstructured": "Yurgelun MB, Allen B, Kaldate RR et al (2015) Identification of a variety of mutations in cancer predisposition genes in patients with suspected Lynch syndrome. Gastroenterology 149(3):604 – 13.e20. \n                    https://doi.org/10.1053/j.gastro.2015.05.006",
      "volume": "149",
      "year": "2015"
    },
    {
      "DOI": "10.1038/modpathol.2016.135",
      "author": "KL Ring",
      "doi-asserted-by": "publisher",
      "first-page": "1381",
      "issue": "11",
      "journal-title": "Mod Pathol",
      "key": "117_CR43",
      "unstructured": "Ring KL, Bruegl AS, Allen BA et al (2016) Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort. Mod Pathol 29(11):1381–1389. \n                    https://doi.org/10.1038/modpathol.2016.135",
      "volume": "29",
      "year": "2016"
    },
    {
      "DOI": "10.1001/jamaoncol.2016.5194",
      "author": "R Pearlman",
      "doi-asserted-by": "publisher",
      "first-page": "464",
      "issue": "4",
      "journal-title": "JAMA Oncol",
      "key": "117_CR44",
      "unstructured": "Pearlman R, WL F, Swanson B (2017) al et. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol 3(4):464–471. \n                    https://doi.org/10.1001/jamaoncol.2016.5194",
      "volume": "3",
      "year": "2017"
    },
    {
      "DOI": "10.1053/j.gastro.2017.11.004",
      "author": "EM Stoffel",
      "doi-asserted-by": "publisher",
      "first-page": "897",
      "issue": "4",
      "journal-title": "Gastroenterology",
      "key": "117_CR45",
      "unstructured": "Stoffel EM, Koeppe E, Everett J et al (2018) Germline genetic features of young individuals with colorectal cancer. Gastroenterology 154(4):897–905. \n                    https://doi.org/10.1053/j.gastro.2017.11.004",
      "volume": "154",
      "year": "2018"
    },
    {
      "DOI": "10.1200/JCO.2012.46.9403",
      "author": "SM Domchek",
      "doi-asserted-by": "publisher",
      "journal-title": "J Clin Oncol",
      "key": "117_CR46",
      "unstructured": "Domchek SM, Bradbury A, Garber JE, Offit K, Robson ME (2013) Multiplex genetic testing for cancer susceptibility: out on the high wire without a net? J Clin Oncol. \n                    https://doi.org/10.1200/JCO.2012.46.9403",
      "year": "2013"
    },
    {
      "DOI": "10.1038/gim.2018.12",
      "author": "BW Katona",
      "doi-asserted-by": "publisher",
      "journal-title": "Genet Med",
      "key": "117_CR47",
      "unstructured": "Katona BW, Yurgelun MB, Garber JE et al (2018) A counseling framework for moderate-penetrance colorectal cancer susceptibility genes. Genet Med. \n                    https://doi.org/10.1038/gim.2018.12",
      "year": "2018"
    },
    {
      "DOI": "10.1200/JCO.2016.71.6480",
      "author": "AW Kurian",
      "doi-asserted-by": "publisher",
      "first-page": "2232",
      "issue": "20",
      "journal-title": "J Clin Oncol",
      "key": "117_CR48",
      "unstructured": "Kurian AW, Li Y, Hamilton AS et al (2017) Gaps in incorporating germline genetic testing into treatment decision-making for early-stage breast cancer. J Clin Oncol 35(20):2232–2239. \n                    https://doi.org/10.1200/JCO.2016.71.6480",
      "volume": "35",
      "year": "2017"
    },
    {
      "DOI": "10.1200/JCO.2018.36.18_suppl.LBA1509",
      "author": "A Latham Schwark",
      "doi-asserted-by": "publisher",
      "first-page": "LBA1509",
      "issue": "18_suppl",
      "journal-title": "J Clin Oncol",
      "key": "117_CR49",
      "unstructured": "Latham Schwark A, Srinivasan P, Kemel Y et al (2018) Pan-cancer microsatellite instability to predict for presence of Lynch syndrome. J Clin Oncol 36(18_suppl):LBA1509–LBA1509. \n                    https://doi.org/10.1200/JCO.2018.36.18_suppl.LBA1509",
      "volume": "36",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s10689-013-9615-1",
      "author": "E Barrow",
      "doi-asserted-by": "publisher",
      "first-page": "229",
      "issue": "2",
      "journal-title": "Fam Cancer",
      "key": "117_CR50",
      "unstructured": "Barrow E, Hill J, Evans DG (2013) Cancer risk in Lynch syndrome. Fam Cancer 12(2):229–240. \n                    https://doi.org/10.1007/s10689-013-9615-1",
      "volume": "12",
      "year": "2013"
    },
    {
      "DOI": "10.1002/humu.22262",
      "author": "JG Dowty",
      "doi-asserted-by": "publisher",
      "first-page": "490",
      "issue": "3",
      "journal-title": "Hum Mutat",
      "key": "117_CR51",
      "unstructured": "Dowty JG, Win AK, Buchanan DD et al (2013) Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat 34(3):490–497. \n                    https://doi.org/10.1002/humu.22262",
      "volume": "34",
      "year": "2013"
    },
    {
      "DOI": "10.1136/gutjnl-2017-314057",
      "author": "P Møller",
      "doi-asserted-by": "publisher",
      "first-page": "1306 LP",
      "issue": "7",
      "journal-title": "Gut",
      "key": "117_CR52",
      "unstructured": "Møller P, Seppälä TT, Bernstein I et al (2018) Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut 67(7):1306 LP–L1316",
      "volume": "67",
      "year": "2018"
    },
    {
      "DOI": "10.1016/S0016-5085(17)32003-6",
      "author": "A Sanchez",
      "doi-asserted-by": "publisher",
      "first-page": "S552",
      "issue": "5",
      "journal-title": "Gastroenterology",
      "key": "117_CR53",
      "unstructured": "Sanchez A, Navarro M, Ocaña T et al (2017) Colorectal cancer incidence in Lynch syndrome patients: first report of a Multicenter Nation-Wide Study. Gastroenterology 152(5):S552. \n                    https://doi.org/10.1016/S0016-5085(17)32003-6",
      "volume": "152",
      "year": "2017"
    },
    {
      "DOI": "10.1200/JCO.2018.78.4777",
      "doi-asserted-by": "publisher",
      "key": "117_CR54",
      "unstructured": "ten Broeke SW, van der Klift HM, Tops CMJ et al. Cancer risks for PMS2 -associated Lynch syndrome. J Clin Oncol. \n                    https://doi.org/10.1200/JCO.2018.78.4777"
    },
    {
      "DOI": "10.1053/j.gastro.2018.07.030",
      "author": "C Engel",
      "doi-asserted-by": "publisher",
      "journal-title": "Gastroenterology",
      "key": "117_CR55",
      "unstructured": "Engel C, Vasen HF, Seppala T et al (2018) No difference in colorectal cancer incidence or stage at detection by colonoscopy among 3 countries with different Lynch syndrome surveillance policies. Gastroenterology. \n                    https://doi.org/10.1053/j.gastro.2018.07.030",
      "year": "2018"
    },
    {
      "DOI": "10.1136/gutjnl-2015-309675",
      "author": "P Møller",
      "doi-asserted-by": "publisher",
      "first-page": "464",
      "issue": "3",
      "journal-title": "Gut",
      "key": "117_CR56",
      "unstructured": "Møller P, Seppälä T, Bernstein I et al (2017) Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut 66(3):464–472. \n                    https://doi.org/10.1136/gutjnl-2015-309675",
      "volume": "66",
      "year": "2017"
    },
    {
      "DOI": "10.1073/pnas.231326898",
      "author": "I Saeterdal",
      "doi-asserted-by": "publisher",
      "first-page": "13255",
      "issue": "23",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "117_CR57",
      "unstructured": "Saeterdal I, Bjorheim J, Lislerud K et al (2001) Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci USA 98(23):13255–13260. \n                    https://doi.org/10.1073/pnas.231326898",
      "volume": "98",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S1470-2045(17)30512-0",
      "author": "F Sclafani",
      "doi-asserted-by": "publisher",
      "first-page": "1141",
      "issue": "9",
      "journal-title": "Lancet Oncol",
      "key": "117_CR58",
      "unstructured": "Sclafani F (2017) PD-1 inhibition in metastatic dMMR/MSI-H colorectal cancer. Lancet Oncol 18(9):1141–1142. \n                    https://doi.org/10.1016/S1470-2045(17)30512-0",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1200/JCO.2017.76.9901",
      "author": "MJ Overman",
      "doi-asserted-by": "publisher",
      "first-page": "773",
      "issue": "8",
      "journal-title": "J Clin Oncol",
      "key": "117_CR59",
      "unstructured": "Overman MJ, Lonardi S, Wong KYM et al (2018) Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol 36(8):773–779. \n                    https://doi.org/10.1200/JCO.2017.76.9901",
      "volume": "36",
      "year": "2018"
    },
    {
      "DOI": "10.1016/S1470-2045(17)30422-9",
      "author": "MJ Overman",
      "doi-asserted-by": "publisher",
      "first-page": "1182",
      "issue": "9",
      "journal-title": "Lancet Oncol",
      "key": "117_CR60",
      "unstructured": "Overman MJ, McDermott R, Leach JL et al (2017) Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol 18(9):1182–1191. \n                    https://doi.org/10.1016/S1470-2045(17)30422-9",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1056/NEJMoa1500596",
      "author": "DT Le",
      "doi-asserted-by": "publisher",
      "first-page": "2509",
      "issue": "26",
      "journal-title": "N Engl J Med",
      "key": "117_CR61",
      "unstructured": "Le DT, Uram JN, Wang H et al (2015) PD-1 Blockade in tumors with mismatch-repair deficiency. N Engl J Med 372(26):2509–2520. \n                    https://doi.org/10.1056/NEJMoa1500596",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1126/science.aan6733",
      "author": "DT Le",
      "doi-asserted-by": "publisher",
      "first-page": "409",
      "issue": "6349",
      "journal-title": "Science",
      "key": "117_CR62",
      "unstructured": "Le DT, Durham JN, Smith KN et al (2017) Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357(6349):409–413. \n                    https://doi.org/10.1126/science.aan6733",
      "volume": "357",
      "year": "2017"
    },
    {
      "DOI": "10.1200/JCO.2014.58.9952",
      "author": "M Movahedi",
      "doi-asserted-by": "publisher",
      "first-page": "3591",
      "issue": "31",
      "journal-title": "J Clin Oncol",
      "key": "117_CR63",
      "unstructured": "Movahedi M, Bishop DT, Macrae F et al (2015) Obesity, aspirin, and risk of colorectal cancer in carriers of hereditary colorectal cancer: a prospective investigation in the CAPP2 study. J Clin Oncol 33(31):3591–3597. \n                    https://doi.org/10.1200/JCO.2014.58.9952",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1073/pnas.1608077113",
      "author": "A Spira",
      "doi-asserted-by": "publisher",
      "first-page": "10750",
      "issue": "39",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "117_CR64",
      "unstructured": "Spira A, Disis ML, Schiller JT et al (2016) Leveraging premalignant biology for immune-based cancer prevention. Proc Natl Acad Sci USA 113(39):10750–10758. \n                    https://doi.org/10.1073/pnas.1608077113",
      "volume": "113",
      "year": "2016"
    },
    {
      "DOI": "10.1053/j.gastro.2008.01.015",
      "author": "Y Schwitalle",
      "doi-asserted-by": "publisher",
      "first-page": "988",
      "issue": "4",
      "journal-title": "Gastroenterology",
      "key": "117_CR65",
      "unstructured": "Schwitalle Y, Kloor M, Eiermann S et al (2008) Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology 134(4):988–997. \n                    https://doi.org/10.1053/j.gastro.2008.01.015",
      "volume": "134",
      "year": "2008"
    },
    {
      "DOI": "10.1038/s41598-018-30466-x",
      "doi-asserted-by": "publisher",
      "key": "117_CR66",
      "unstructured": "Majumder S, Shah R, Elias J et al (2018) A cancer vaccine approach for personalized treatment of Lynch syndrome. \n                    https://doi.org/10.1038/s41598-018-30466-x"
    },
    {
      "DOI": "10.1001/jamaoncol.2018.1482",
      "author": "K Chang",
      "doi-asserted-by": "publisher",
      "first-page": "1085",
      "issue": "8",
      "journal-title": "JAMA Oncol",
      "key": "117_CR67",
      "unstructured": "Chang K, Taggart MW, Reyes-Uribe L et al (2018) Immune profiling of premalignant lesions in patients with Lynch syndrome. JAMA Oncol 4(8):1085–1092. \n                    https://doi.org/10.1001/jamaoncol.2018.1482",
      "volume": "4",
      "year": "2018"
    }
  ],
  "reference-count": 67,
  "references-count": 67,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-018-00117-1"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Recent advances in Lynch syndrome"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "18"
}